These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 15541915)

  • 1. A new method for investigating bioequivalence of inhaled formulations: A pilot study on salbutamol.
    Rezaei H; Khoubnasabjafari M; Jouyban-Gharamaleki V; Hamishehkar H; Afshar Mogaddam MR; Rahimpour E; Mehvar R; Jouyban A
    J Pharm Pharm Sci; 2023; 26():11466. PubMed ID: 37206631
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro dose comparison of Respimat
    Ciciliani AM; Langguth P; Wachtel H
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1565-1577. PubMed ID: 28603412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scientific Rationale for Determining the Bioequivalence of Inhaled Drugs.
    Usmani OS; Molimard M; Gaur V; Gogtay J; Singh GJP; Malhotra G; Derom E
    Clin Pharmacokinet; 2017 Oct; 56(10):1139-1154. PubMed ID: 28290122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation, preclinical and clinical evaluation of a new submicronic arginine respiratory fluid for treatment of chronic obstructive pulmonary disorder.
    Rathor VP; Chugh P; Ali R; Bhatnagar A; Haque SE; Bhatnagar A; Mittal G
    Saudi Pharm J; 2016 Jan; 24(1):49-56. PubMed ID: 26903768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.
    Mitchell J; Newman S; Chan HK
    AAPS PharmSciTech; 2007 Dec; 8(4):E110. PubMed ID: 18181531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalence testing of salbutamol dry powder inhalers: in vitro impaction results versus in vivo efficacy.
    Weda M; Zanen P; de Boer AH; Gjaltema D; Ajaoud A; Barends DM; Frijlink HW
    Int J Pharm; 2002 Dec; 249(1-2):247-55. PubMed ID: 12433452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines.
    Wong W; Crapper J; Chan HK; Traini D; Young PM
    J Pharm Biomed Anal; 2010 Mar; 51(4):853-7. PubMed ID: 19932579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerodynamic deposition of combination dry powder inhaler formulations in vitro: a comparison of three impactors.
    Taki M; Marriott C; Zeng XM; Martin GP
    Int J Pharm; 2010 Mar; 388(1-2):40-51. PubMed ID: 20026261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhalation behaviour and therapeutical response of salbutamol particles administered from two metered dose aerosols.
    Vidgren P; Silvasti M; Vidgren M; Paronen P; Tukiainen H; Lehti H
    Pharmazie; 1991 Jan; 46(1):41-3. PubMed ID: 1857729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the predictive value of cascade impactor results for side effects of inhaled salbutamol.
    Weda M; Zanen P; de Boer AH; Barends DM; Frijlink HW
    Int J Pharm; 2004 Dec; 287(1-2):79-87. PubMed ID: 15541915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of Aerodynamic Particle Size Distribution of Orally Inhaled Products by Cascade Impactor: How to Let the Product Specification Drive the Quality Requirements of the Cascade Impactor.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2019 Jan; 20(2):57. PubMed ID: 30623259
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.